318
Views
62
CrossRef citations to date
0
Altmetric
Articles

Design and development of novel focal adhesion kinase (FAK) inhibitors using Monte Carlo method with index of ideality of correlation to validate QSAR

ORCID Icon, &
Pages 63-80 | Received 18 Oct 2018, Accepted 24 Dec 2018, Published online: 22 Feb 2019
 

ABSTRACT

Quantitative structure-activity relationship (QSAR) modelling of 55 focal adhesion kinase (FAK) (EC 2.7.10.2) inhibitors of triazinic nature was performed using the Monte Carlo method. The QSAR models were designed by CORAL software, and optimal descriptors were calculated with the simplified molecular input line entry system (SMILES). Four splits were made from the triazinic derivative data by random division into training, invisible training, calibration and validation sets. The QSAR results from these four random splits were robust, very simple, predictive and reliable. The best statistical parameters of the validation set (r2 = 0.8398 and Q2 = 0.7722) for the QSAR equation for split 3 with IIC = 0.9127 were obtained. The predictive potential of QSAR models of FAK inhibitors was explored by applying the index of ideality of correlation (IIC), which is a new criterion for the prediction of the potential for quantitative structure–property activity relationships (QSPRs/QSARs). The present method follows OECD principles.

Acknowledgements

The authors are grateful to Dr Andrey A. Toropov and Dr Alla P. Toropova for providing CORAL software.

Disclosure statement

The authors declare that there are no conflicts of interest.

Supplementary material

Supplementary material for this article can be accessed at: https://doi.org/10.1080/1062936X.2018.1564067

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.